SOMI Creative
GLP-1 Weight Loss - US (Need Proof)
Active
Created 2026/11/19
Updated 15 hours ago

DESCRIPTION
PROOF REQUIREDDescription: Physician-supervised weight-loss treatment.Includes: Semaglutide and tirzepatide options.Primary revenue audience: Women 35–44Strongest paid-media segment: Women 45–54FTC disclosure: Clearly and conspicuously disclose the m ...
SHOW MORE
YOU MAY LIKE
$ 24.95
$ 200.00
$ 160.00
$ 112.50
$ 60.00
$ 225.00
$ 150.00
$ 120.00
$ 220.00
$ 224.00
Load More























